Cohesive Technologies Inc. Announces Development, Sales, and Support Agreement with Applied Biosystems
12 Febbraio 2004 - 5:55PM
PR Newswire (US)
Cohesive Technologies Inc. Announces Development, Sales, and
Support Agreement with Applied Biosystems FRANKLIN, Mass., Feb. 12
/PRNewswire/ -- Cohesive Technologies Inc.
(http://www.cohesivetech.com/), developers of TurboFlow(R), a
technology for high throughput liquid chromatography systems,
announced today that it has entered into a development, sales, and
support agreement with Applied Biosystems Group , an Applera
Corporation business. The agreement covers LC/MS/MS systems jointly
developed by Applied Biosystems and MDS Inc. , through its Applied
Biosystems/MDS Sciex instrument partnership, a supplier of mass
spectrometers and other analytical instrumentation. Because the
companies have complementary products and technologies, this
agreement allows Cohesive and Applied Biosystems to jointly provide
their customers with a complete, seamless, integrated, high
throughput system for bioanalysis in drug development. Cohesive's
patented chromatography systems, offering increased productivity
and throughput, sample prep elimination, and high sensitivity, will
be integrated with the Applied Biosystems/MDS Sciex product line of
highly sensitive mass spectrometers. Under this agreement, Cohesive
Technologies and Applied Biosystems agree to broaden their
collaboration on joint system development, including modifying
software to provide seamless management and single point control of
all system functions, and developing new applications for the
combined technologies. "Our industry leading technology and
recently expanded strategic collaboration with Applied Biosystems
enables us to build on our combined strength in bioanalysis, and
provides an opportunity to integrate liquid chromatography/mass
spectrometry systems closer than ever before for our customers,"
said Peter H. Glick, President and CEO of Cohesive Technologies.
"We look forward to continuing our strong collaboration with
Applied Biosystems to maximize the significant opportunities that
our companies' technologies present." Cohesive Technologies
develops, manufactures, and markets novel liquid chromatography
systems and chemistries for the pharmaceutical and biotechnology
marketplace. Cohesive's high throughput liquid chromatography
systems have been shown to dramatically increase speed and reduce
costs of bioanalytical testing for drug discovery and development.
Researchers at dozens of major pharmaceutical and biotechnology
companies have published results indicating up to a four-fold
increase in sample throughput usingCohesive's multiplexing and
patented TurboFlow(R) technologies. The Company has over 300
systems installed worldwide. DATASOURCE: Cohesive Technologies Inc.
CONTACT: Jeff Zonderman, Director of Sales of Cohesive Technologies
Inc., +1-508-520-5533
Copyright